KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Yumanity Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Yumanity Therapeutics, Inc. is YMTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Yumanity Therapeutics, Inc. Stock?
Yumanity Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Yumanity Therapeutics, Inc. Stock?
Yumanity Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Yumanity Therapeutics, Inc. Stock.

What's the current price of Yumanity Therapeutics, Inc. Stock?
As of the end of day on the Mar 15, 2023, the price of an Yumanity Therapeutics, Inc. (YMTX) share was $1.76.

What is the 52-week high and low for Yumanity Therapeutics, Inc. Stock?
The 52-week high for Yumanity Therapeutics, Inc. Stock is $2.49 and the 52-week low is $0.97.

What is the market capitalization of Yumanity Therapeutics, Inc. Stock?
As of the Mar 15, 2023, the market capitalization of Yumanity Therapeutics, Inc. is 15.721M.
Click to get the best stock tips daily for free!

About Yumanity Therapeutics, Inc.

Yumanity Therapeutics. Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead p... YMTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT